Intervention to Increase Chemotherapy Tolerance in Elderly Cancer Patients
Status unconfirmed · Not applicable
Conditions studied: Colonic Neoplasms
In brief
The purpose of this study is to develop and pilot test a behavioral intervention for elderly adults in treatment for colon cancer, to enhance their skills for managing the challenges of completing chemotherapy regimens. The investigators will assess feasibility and acceptability of the intervention, and explore preliminary efficacy of the intervention for reducing psychological distress and improving rates of optimal chemotherapy adherence.
Key facts
- Study ID
- NCT01586416
- Run by
- Massachusetts General Hospital
- People needed
- 15
- Starts
- 2012-12-01
- Expected to finish
- 2020-12-01
- Last updated by the study team
- 2020-09-02
Who can join
Age: 60 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Age 60 or older
- Verbal fluency in English
- Diagnosis of colon cancer
- Scheduled to initiate chemotherapy treatment for colon cancer
You may not qualify if…
- Active, unstable, untreated serious mental illness interfering with ability to participate
- Cognitive impairment interfering with ability to participate
- Receiving radiotherapy concomitant with chemotherapy
Where it is running
- Massachusetts General Hospital — Boston, Massachusetts, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.